Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
M ODULE F: P RE - STUDY A SSESSMENT V ISIT Denise Thwing 14 Apr Version: Final 14-Apr-2010.
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
GCP for Investigators Tina Lidén Mascher, Kvalitetsregister, forskning och industrisamarbeten.
Research Coordination Guidance The Committees on Human Research Serving University of Vermont & Fletcher Allen Health Care
The IND and Clinical Trial Management Frances Richmond Director International Center for Clinical Trials.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Determining % Effort for Clinical Trial Kathy Price, RN, MBA Manager, GI Clinical Research.
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Clinical Trial Infrastructure in Centres Lillian L. Siu Princess Margaret Hospital.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
6/1/09.
Planning and Surviving An Audit/Monitoring visit Carmen B. Jacobs, BS, RN,OCN, CCRP U.T. MD Anderson Cancer Center Houston, Texas U.S.A.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
STUDY CLOSE OUT KEMRI-Wellcome Trust Research Programme Version: 4-Nov-2008.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
Research Studies GOTCHA’S By Sally Duffy. Failure to follow protocol, investigator agreements and regulations Did not use device/drug in manner specified.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Site Monitoring Shirley Frederiksen Donna Harsh.
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
How to Start An Industry Sponsored Clinical Trial
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
Sponsor Visits and Monitoring
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Supervisory Responsibilities of Clinical Investigators
Remote Site Initiation Visits
Clinical Trial Budgets
Design of Case Report Forms
PRCSG Training Webinar: Budget for Industry Sponsored Studies
Collaborative Practice Agreements
The Role and Responsibilities of the Clinical Research Coordinator
Responsibilities of Sponsor, Investigator and Monitor
Study Feasibility and Start-up
MAINTAINING THE INVESTIGATOR’S SITE FILE
New Coordinator CRU Orientation
Alyssa Speier, MS, CIP November 13, 2013
Roles and Responsibilities of the Clinical Research Team
Elements of an Organized Regulatory Binder
Basics of Building and Understanding Data Collection Forms
ARCADIA Coordinator Webinar
Getting a Study Done at Jefferson:
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Clinical Trial Budgets
Clinical Trial Budgets
TRTO (Translational Research Trials Office)
Responsibilities of the Principal Investigator
Monitoring, Auditing and Compliance
Good clinical practice
Presentation transcript:

Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute

By the end of this presentation you will: Learn about the different types of monitoring visits Understand the objective of each type of monitoring visit Know the expectations of the site by the monitor

Monitoring Monitoring is a very important aspect of a trial Monitoring is the act of overseeing the progress of a clinical trial and ensuring that it is conducted in accordance with the protocol, SOPs, GCP, and any other regulatory requirements The monitor or Clinical Research Associate (CRA) acts as a liaison between the site and the sponsor

Types of Monitoring Visits The most common types of site visits for industry-sponsored studies are: Site Evaluation (Pre-Study) Visit Site Initiation Visit Interim Monitoring Visit Close Out Site Visit

Site Evaluation Visit This visit is conducted to evaluate a site’s and investigator’s resources and capabilities to conduct a study in terms of site infrastructure, adequacy and availability of the site facilities for study conduct

What are they looking for at Site Evaluation Visit? Investigator Qualifications Up to date CV Principal Investigators expertise in the Specialty Previous experience in conducting a trial Adequate resources Sufficient time Adequate staffing Population

What are they looking for at Site Evaluation Visit? Adequate Facilities Exam Rooms Pharmacy/Study Drug Storage area Laboratory or specimen processing area Special testing areas (x-rays, MRIs, CT scans, etc.…) Record keeping facilities – regulatory binders, CRFs, Off site storage

What are they looking for at Site Evaluation Visit? Protocol review and discussion Study objectives Inclusion/exclusion criteria Study procedures/tests Schedule of assessments Competing trials

How can you make this visit go smoothly? Make sure everyone who needs to attend this visit is given ample time to make room in their schedules Have updated (signed and dated) CVs and current licenses for all key players Usually the monitors only need 1 hour with the PI so you can work this visit around the PI’s schedule If you need to visit another department (i.e radiology or Investigational Pharmacy) please be sure they are aware of the visit

Site Initiation Visit The Site Initiation Visit is planned to provide study-specific information to investigators and staff prior to study start-up and to reassess resources and capabilities of the site to conduct the research study The monitor will also discuss with the staff about research obligations as per the GCP. The monitor provides necessary guidance to the site to help the site be successful

What happens at the Site Initiation Visit? Review of Investigator responsibilities Protocol Overview Discussion of General Study Procedures Safety: Definitions, Collection, and Reporting of AE/SAE Data Collection/Source Documentation Investigational Product

What happens at the Site Initiation Visit? Specimen Processing Clinical Monitoring Plan Regulatory Documents Review Tour of Facility Review of any action items This could also count as training for others who did not attend an Investigator Meeting

QUESTIONS?

Interim Monitoring Visit Routine or Interim Monitoring visits are basically any visit that occurs after the site is initiated and up until the site is closed out The objective of these visits is to assess the progress of the trial in terms of accuracy, completeness and verification of reported trial data

What information is reviewed during the visit? Informed Consent Documents Study subjects research records Source documentation Regulatory binders Occurrence and reporting of adverse events and protocol deviations Action items from previous monitoring visit

Other Comments about monitor visits Monitors usually come out an average of every three months for a one day visit. This may vary depending on the study and enrollment It is expected that your monitor will come out within 2 weeks of you enrolling your first patient You must provide for your monitor a desk or other ample space in a fairly quiet area with access to a telephone and an internet connection They also will want to meet with the PI for a few minutes to discuss the study and any other issues or concerns

What Can You Do To Make These Visits Stress Free? Complete all notes and enter all visit data in a timely manner As soon as you get your Monitoring Visit Follow-Up letter from the previous monitoring visit review and complete all action items as soon as possible Answer all queries promptly Review patient medical records on a regular basis to capture any adverse events Think like a monitor

QUESTIONS?

Close Out Site Visit The close out visit occurs after study completion or site withdrawal In general, three activities are required to “officially” close out a site The monitor conducts a close-out visit and signs the monitoring log The Principal investigator submits a final report to the IRB stating that the site is closed The sponsor sends a letter stating that the site is closed

What happens at a Close out visit? The monitor conducts a final data review/collection of all outstanding data Study drug is returned or destroyed on site A final review of the regulatory binder is done And, if applicable, verification that all blood/biological samples have been submitted Return or destruction of all unused forms/CRFs Review and collection of Delegation of Authority forms and other “original” logs Collection of IRB closure report/letter

What Steps Can You Take To Have a Stress Free Close Out Visit? Insure that all logs are up to date and accurate Make sure all logs that need the PI signature are signed prior to the monitor visit Have copies of any temperature logs ready to give to the monitor Review the Regulatory Files and Patient binders with a monitor’s “eye” to make sure everything is in order

QUESTIONS?

Thank You!